Malcolm Lloyd-Smith is Chief Integration Officer at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 24 open-market trades across 1 company since 2013, most recently 2023-02-08.
CIK 0001557146
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL | 2023-02-06 | 2023-02-08 | $102.64 | $3.1M | -2.5% | -8.5% | -7.2% |
| NBIX | SELL | 2023-01-31 | 2023-02-02 | $110.02 | $367K | -5.8% | -7.8% | -9.8% |
| NBIX | SELL | 2022-08-12 | 2022-08-16 | $105.95 | $4.6M | -1.1% | +0.8% | +11.3% |
| NBIX | SELL | 2022-02-07 | 2022-02-09 | $80.48 | $544K | +10.7% | +12.7% | +3.8% |
| NBIX | SELL | 2021-07-27 | 2021-07-29 | $93.80 | $3.1M | -5.7% | +3.7% | +9.5% |
| NBIX | SELL | 2021-02-10 | 2021-02-12 | $119.96 | $204K | -5.8% | -14.4% | -19.0% |
| NBIX | SELL | 2021-02-05 | 2021-02-09 | $116.26 | $959K | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2021-01-25 | 2021-01-27 | $119.96 | $4.3M | +6.2% | -1.2% | -11.8% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.73 | $410K | +3.1% | +6.5% | +21.3% |
| NBIX | SELL | 2020-08-05 | 2020-08-07 | $118.86 | $537K | -1.6% | -4.5% | -12.7% |
| NBIX | SELL | 2020-04-24 | 2020-04-28 | $99.45 | $385K | +9.0% | +19.8% | +25.5% |
| NBIX | SELL | 2020-02-07 | 2020-02-11 | $104.52 | $6.3M | -9.5% | -24.4% | +6.0% |
| NBIX | SELL | 2020-02-05 | 2020-02-07 | $102.38 | $704K | -0.4% | -14.6% | +5.2% |
| NBIX | SELL | 2019-10-14 | 2019-10-16 | $90.85 | $1.8M | +4.1% | +19.7% | +14.2% |
| NBIX | SELL | 2019-02-06 | 2019-02-08 | $83.58 | $154K | -8.8% | -5.6% | -7.0% |
| NBIX | SELL | 2019-02-05 | 2019-02-06 | $88.15 | $224K | -3.2% | -8.0% | -6.5% |
| NBIX | SELL | 2018-11-06 | 2018-11-08 | $110.01 | $990K | -17.6% | -20.1% | -21.4% |
| NBIX | SELL | 2018-02-05 | 2018-02-07 | $83.19 | $160K | +1.8% | +11.2% | -0.1% |
| NBIX | SELL | 2018-01-02 | 2018-01-04 | $77.52 | $2.8M | -6.3% | +0.6% | -1.3% |
| NBIX | SELL | 2017-05-18 | 2017-05-23 | $53.26 | $265K | -10.7% | -6.7% | +3.2% |
| NBIX | SELL | 2017-05-18 | 2017-05-23 | $53.63 | $534K | -10.7% | -6.7% | +3.2% |
| NBIX | SELL | 2017-04-12 | 2017-04-13 | $50.42 | $1.3M | -0.4% | -1.0% | -13.5% |
| NBIX | SELL · 10b5-1 | 2017-02-06 | 2017-02-08 | $43.35 | $37K | +0.0% | +5.5% | +19.8% |
| NBIX | SELL | 2016-09-01 | 2016-09-02 | $50.00 | $450K | +6.0% | +0.9% | -13.1% |
| NBIX | SELL | 2016-05-31 | 2016-06-02 | $50.00 | $450K | -8.6% | -9.7% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.